Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Healthcare system barriers impacting the care of Canadians with myalgic encephalomyelitis: a scoping review

Said Hussein, Lauren Eiriksson, Maureen MacQuarrie, Scot Merriam, View ORCID ProfileMaria Dalton, Eleanor Stein, View ORCID ProfileRosie Twomey
doi: https://doi.org/10.1101/2023.09.20.23295809
Said Hussein
1Cumming School of Medicine, University of Calgary, Calgary, AB;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lauren Eiriksson
2Faculty of Kinesiology, University of Calgary, Calgary, AB;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maureen MacQuarrie
LLB
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scot Merriam
BASc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Dalton
1Cumming School of Medicine, University of Calgary, Calgary, AB;
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maria Dalton
Eleanor Stein
1Cumming School of Medicine, University of Calgary, Calgary, AB;
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosie Twomey
2Faculty of Kinesiology, University of Calgary, Calgary, AB;
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rosie Twomey
  • For correspondence: Rosemary.Twomey{at}ucalgary.ca
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Myalgic encephalomyelitis (ME, also known as chronic fatigue syndrome or ME/CFS) is a debilitating, complex, multi-system illness. Developing a comprehensive understanding of the multiple and interconnected barriers to optimal care will help advance strategies and care models to improve quality of life for people living with ME in Canada.

Objectives To: (1) identify and systematically map the available evidence; (2) investigate the design and conduct of research; (3) identify and categorize key characteristics; and (4) identify and analyze knowledge gaps related to healthcare system barriers for people living with ME in Canada.

Methods The protocol was preregistered in July 2022. Peer-reviewed and grey literature was searched, and patient partners retrieved additional records. Eligible records were Canadian, included people with ME/CFS and included data or synthesis relevant to healthcare system barriers.

Results In total, 1821 records were identified, 406 were reviewed in full, and 21 were included. Healthcare system barriers arose from an underlying lack of consensus and research on ME and ME care; the impact of long-standing stigma, disbelief, and sexism; inadequate or inconsistent healthcare provider education and training on ME; and the heterogeneity of care coordinated by family physicians.

Conclusions People living with ME in Canada face significant barriers to care, though this has received relatively limited attention. This synthesis, which points to several areas for future research, can be used as a starting point for researchers, healthcare providers and decision-makers who are new to the area or encountering ME more frequently due to the COVID-19 pandemic.

Funding This study was funded by the University of Calgary (VPR Catalyst Grant) and the Interdisciplinary Canadian Collaborative ME (ICanCME) Research Network (New Frontier ME Discovery Grant).

Competing Interest Statement

ES is a retired physician who provides paid online educational services to people with ME and related diseases. MM was a member of the Ontario Task Force on Environmental Health. SM was the leader of the Nanaimo ME Support Group and involved in the related Physicians Survey. The ICanCME Research Network was funded by a 2019 Catalyst Network grant awarded by CIHR-Institute of Musculoskeletal Health and Arthritis (CIHR-IMHA). During manuscript preparation, RT accepted a position within CIHR-IMHA. RTs involvement with ICanCME was restricted to the publication of existing studies and was terminated thereafter.

Funding Statement

This study was funded by the University of Calgary (VPR Catalyst Grant) and the ICanCME Research Network (New Frontier ME Discovery Grant). During this scoping review, RT was funded by a CIHR Postdoctoral Fellowship.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • ↵3 Patient Partners.

  • ↵* Co-senior author

  • A minor reference error was corrected. A comment was removed (missed in error).

Data Availability

Data produced in the study are contained in Table I and II. Online Supplementary Material can be found at: https://osf.io/ychx3/. Please contact the authors to request additional information.

https://osf.io/ychx3/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 22, 2023.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Healthcare system barriers impacting the care of Canadians with myalgic encephalomyelitis: a scoping review
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Healthcare system barriers impacting the care of Canadians with myalgic encephalomyelitis: a scoping review
Said Hussein, Lauren Eiriksson, Maureen MacQuarrie, Scot Merriam, Maria Dalton, Eleanor Stein, Rosie Twomey
medRxiv 2023.09.20.23295809; doi: https://doi.org/10.1101/2023.09.20.23295809
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Healthcare system barriers impacting the care of Canadians with myalgic encephalomyelitis: a scoping review
Said Hussein, Lauren Eiriksson, Maureen MacQuarrie, Scot Merriam, Maria Dalton, Eleanor Stein, Rosie Twomey
medRxiv 2023.09.20.23295809; doi: https://doi.org/10.1101/2023.09.20.23295809

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Systems and Quality Improvement
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)